# OnCo record nci-csrn (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/nci-csrn/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "nci-csrn" ;
  schema:name "NCI Cancer Screening Research Network (CSRN)"@en ;
  schema:alternateName "CSRN"@en, "Cancer Screening Research Network"@en ;
  schema:description "A US National Cancer Institute network, led by Fred Hutch Cancer Center in Seattle, that tests new ways of screening for cancer. Its first study, Vanguard, is checking whether blood tests that look for many cancers at once can be studied properly in a large trial."@en ;
  schema:url <https://onco.cc/institutions/nci-csrn/>, <https://prevention.cancer.gov/major-programs/cancer-screening-research-network-csrn> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://prevention.cancer.gov/major-programs/cancer-screening-research-network-csrn>, <https://prevention.cancer.gov/major-programs/cancer-screening-research-network-csrn/vanguard-study> ;
  onco:tag "research-funding" ;
  schema:addressCountry "US" ;
  schema:addressLocality "Seattle" ;
  schema:latitude "47.627"^^xsd:decimal ;
  schema:longitude "-122.332"^^xsd:decimal ;
  onco:technologies <https://onco.cc/technologies/mced/> ;
  onco:drugs <https://onco.cc/drugs/avantect-mcd/>, <https://onco.cc/drugs/shield-mcd/> ;
  onco:companies <https://onco.cc/companies/clearnote-health/>, <https://onco.cc/companies/guardant-health/> ;
  onco:institutions <https://onco.cc/institutions/nci/>, <https://onco.cc/institutions/fred-hutch/> ;
  onco:trials <https://onco.cc/trials/vanguard-study/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-overdiagnosis/> .